Skip to main content

Kornitzer Benjamin's Form 4 filing

agilon health, inc. (AGL) · filed Jul 19, 2022

Accession no.
0001209191-22-042547
Filed
Jul 19, 2022
Trade date
Jul 15-18, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $427.5K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kornitzer BenjaminCIK 0001855842Officer (Chief Med. & Quality Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 15, 2022Common StockMOption exerciseAcquired+8,094$4.49+$36,342.0618,947Direct
Jul 15, 2022Common StockSSaleDisposed−8,094$26.25F3−$212,467.510,853Direct
Jul 18, 2022Common StockMOption exerciseAcquired+8,094$4.49+$36,342.0618,947Direct
Jul 18, 2022Common StockSSaleDisposed−8,094$26.57F4−$215,057.5810,853Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 15, 2022Common StockMOption exerciseDisposed−8,094$0.00$0417,115Direct
Jul 18, 2022Common StockMOption exerciseDisposed−8,094$0.00$0409,021Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.09 to $26.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.265 to $26.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)